Selectis Health (GBCS) Receivables (2013 - 2025)

Selectis Health has disclosed Receivables across 12 years of filings, most recently posting $3.1 million for Q4 2025.

• Receivables for Q4 2025 came in at $3.1 million, down 6.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.1 million (down 6.29% YoY), and the FY2025 annual result was $3.1 million, down 6.29% from the prior year.
• Receivables came in at $3.1 million for Q4 2025 at Selectis Health, down from $3.2 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $4.7 million in Q2 2022 to a low of $1.8 million in Q1 2024.
• The 5-year median for Receivables is $3.1 million (2022), against an average of $3.1 million.
• Across the five-year window, Receivables jumped 133.18% in 2021 and plunged 45.19% in 2023, its largest moves.
• Selectis Health's Receivables stood at $4.4 million in 2021, then retreated by 10.53% to $3.9 million in 2022, then fell by 25.36% to $2.9 million in 2023, then climbed by 14.32% to $3.3 million in 2024, then slipped by 6.29% to $3.1 million in 2025.
• The last three Receivables figures came in at $3.1 million (Q4 2025), $3.2 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.